SHARING IDEAS THAT DO GOOD

Aussie biotech receives approval for COVID-19 tests in Europe

post-image
Australian biotech Microbio has had their InfectID-COVID-19 tests approved for sale in Europe. A revolutionary pathogen identification test, InfectID is a rapid, highly sensitive and adaptable test which addresses different target pathogens. Two SARS-CoV-2 tests by Microbio have been developed and received approval for sale in Europe under IVD Directive 98/79/EC. This approval enables the privately held scale-up to move into additional international markets, including India, North America, Africa, and Asia. The tests have a 100% success rate and have been compared to other real-time Polymerase Chain Reaction (PCR) tests that claim to detect all variants. | shorturl.at/zFMNY
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

11 November 2021



Related Posts

Healthcare

post-image

An exoskeleton that neutralises spasms
4 January 2022 by Lynn Wood 0 Comments

Healthcare

post-image

An eye-drop that improves close range vision
3 January 2022 by Lynn Wood 0 Comments

Healthcare

post-image

A quiet scientific revolution that may solve chronic pain
28 December 2021 by Lynn Wood 0 Comments